mitotane has been researched along with Acute Porphyria in 1 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitotane therapy was discontinued but the attack of porphyria persisted for more than four months and included episodes with severe metabolic and neurologic toxicities." | 1.37 | [Mitotane as possible cause of acute intermittent porphyria]. ( von Eyben, FE, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Eyben, FE | 1 |
1 other study available for mitotane and Acute Porphyria
| Article | Year |
|---|---|
[Mitotane as possible cause of acute intermittent porphyria].
Topics: Adrenal Cortex Neoplasms; Antineoplastic Agents, Hormonal; Female; Humans; Middle Aged; Mitotane; Po | 2011 |